The European Partnership for Personalised Medicine (EP PerMed) has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over € 36.5 Mio.
The topics of this call are the following:
- “identification of new pharmacogenomic markers or signatures using (multi)-omics data in relation to drug or drug combination.
- validation of a pharmacogenomic marker or signatures using (multi)-omics data in predicting drug or drug combination outcomes.
- use pharmaco-omics strategies to determine the right dosage, the efficacy of treatments and/or the risk of adverse drug response and non-response to treatment to tailor personalised treatment pathways, including combined treatments (multi-medication).”
Pay attention: projects focussing only on drug-drug-interaction and projects focusing on the clinical development of new drugs are not eligible.
Research Foundation Flanders (FWO) participates in this call. More information on available funding for researchers based in Flanders and on how to apply can be found on the dedicated FWO webpage. Interested to apply? Contact the FWO advisors at europe@fwo.be. Deadline for pre-proposal submission AND national pre-application via the FWO e-loket is 18 February 2025, 14:00 CET.